Vietnam Begins First Human Trials Of Bird Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
Vietnam researchers began the first human test of a locally developed bird flu vaccine, beginning with 24 military students. The Phase I trial is being conducted by the Military Medical Institute, which plans two inoculations of the participants, 28 days apart. The H5N1 vaccine was developed by the Vaccine and Bio-Technology Products Company No. 1, which already has produced 100,000 doses and is prepared to mass-produce the vaccine by the middle of next year if the trials prove successful. (Click here for more
You may also be interested in...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.